Identification of novel human CTL epitopes and their agonist epitopes of mesothelin. - Wikidata - wikimedia - TriplyDB

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

http://www.wikidata.org/entity/Q34313298

about

Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer Mesothelin targeted cancer immunotherapy Antigen-specific immunotherapy of cervical and ovarian cancer Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside.Strategies for cancer vaccine development.The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells.Investigational approaches for mesothelioma.Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.Expansion of anti-mesothelin specific CD4+ and CD8+ T cell responses in patients with pancreatic carcinoma.Control of mesothelin-expressing ovarian cancer using adoptive transfer of mesothelin peptide-specific CD8+ T cells.T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology.New targeted therapies in pancreatic cancer.Mesothelin-targeted agents in clinical trials and in preclinical development.Silencing of the TGF-β1 gene increases the immunogenicity of cells from human ovarian carcinoma.Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer.What is recent in pancreatic cancer immunotherapy?Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells.Potential targets for pancreatic cancer immunotherapeutics.Nanoprobes for hybrid SPECT/MR molecular imaging.CAR T-cell therapy for pancreatic cancer.Study on the mesothelin-specific cytotoxicity against epithelial ovarian cancer with full-length mesothelin cDNA-transduced dendritic cells.Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses.Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer.

P2860

Q24622837-021980A6-EBC5-4026-A581-FDF17D1D86BE Q24651062-42CA042A-C948-40D8-AA1B-846E263ABA4F Q24656242-EE82CD2B-5DEA-4748-B787-6A1416154E68 Q27488697-4851229E-DCC2-4457-83CF-AC6AF38F93AB Q30235405-029ABB6F-4CFC-4A1F-BA78-C004A28E1173 Q33724878-70567696-548D-477B-9C90-36D5D07D2469 Q34038338-8ACC927D-63FF-4B76-AF71-058A4B46C0E2 Q34103645-DDDEE419-A53F-43C7-B1F8-7BF9855DF600 Q34293068-EA9FB243-47BE-4A6B-8656-1E31EF72FF14 Q34642305-BA1EE9CE-A99E-4D4B-B328-36D944E279F3 Q35092711-1B7B80BB-B053-4583-9E7D-247A6DA95C69 Q35244923-1E906AA9-78F1-4D8D-B481-46979A752FB0 Q35550879-A62DF203-428B-4CB5-B6B8-69DFC82B51A6 Q35651453-4FAFD353-F19D-4D3D-9F48-B72B12EB2B4A Q35815380-7DFDA38F-DF50-4E2B-9CD5-FC3590BB556E Q35890860-06E1A17A-2DB2-4792-A368-0EF84578E74D Q36021163-88A72E1C-6307-4AC7-BBA5-5E314A475FA5 Q36639456-2D9383F6-13B0-4803-A440-8D0386B9D690 Q36665335-5C06E218-DB7E-4FBE-9029-7EBDE1C2BD7C Q36857863-3F702066-6729-44C0-A653-EE2A396CC9A2 Q37084335-7612A2EA-76A3-41FF-87B8-07DB617CA423 Q37861220-3924E517-D86E-472B-8C37-3C5F5FFC3D3B Q38013146-C6779D2A-6238-4F16-A817-45D7585C9541 Q39202440-7D7C453E-C08E-4658-850A-93EA7F90F2F8 Q53581193-7C106CCE-CFAD-4591-9F3E-B3F99F66953B Q54941738-35F3D0E4-B71E-4E5A-AEED-7CCDFFB0CB36 Q55001866-32C0E685-7941-4DE7-A350-132AA94C9437

P2860

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

http://www.wikidata.org/entity/Q34313298

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

@ast

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

@en

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

@nl

type

label

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

@ast

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

@en

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

@nl

prefLabel

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

@ast

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

@en

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

@nl

P1433

Q34313298-C6BF9C3B-7637-4BF0-8800-910D77F9BEF2

P1476

Q34313298-733D0CD1-1B6C-4496-80DB-840DE440ABFF

P2093

Q34313298-0ACA333D-8796-4A0E-A9EA-F41DA86CCEE5

Q34313298-8F488D4D-AE0A-4025-AA49-4D1C7C18EB3D

Q34313298-9A478662-69F9-4347-B469-96398FD3BE88

Q34313298-D2E79C73-7BD2-415F-8D25-EF2AFA38A47B

Q34313298-FCBD8BCC-8173-46C9-926D-FE72CF0DD2F2

Q34313298-FF88E382-95FA-4ED1-A8A2-2C64D0C0D92D

Q34313298-FFA1D3F2-E3AD-4DA1-9116-B6863D305B68

Q34313298-FFD1F103-AB8E-4AD5-B436-D69E5781CE41

P2860

Q34313298-102E7009-943E-49E2-864C-A405CD6A8664

Q34313298-145D1390-103C-44D9-B4FA-327402C9B705

Q34313298-193A8163-69EF-4C82-A137-420A777AF447

Q34313298-1BF44A02-087D-4DF4-85DB-C7B640322333

Q34313298-207AB3AB-9C9E-4707-A8D3-0DEA7AD560E5

Q34313298-20D5C033-A9E3-4886-90B8-E9BDF8D28369

Q34313298-275C4633-974B-4DDC-814C-60CF92F2DC79

Q34313298-2A81C308-80F4-46C5-A97B-5E8A61EE238B

Q34313298-3F312843-FF44-4050-8889-178AAD99AE6A

Q34313298-47754E86-0493-4F37-8357-99E9E4774DEA

P304

Q34313298-3A01161B-0536-4034-857B-FCBEDCF962DD

P31

Q34313298-32697202-84F7-4EAE-A3C3-6F213BB46AD8

P356

Q34313298-BB4D86BC-83E1-45A6-8EAC-DF701C6B2A0C

P407

Q34313298-0123ECD7-5B5D-4BFE-B29F-E99723D855C7

P433

Q34313298-87A3832E-85BC-4A2E-8364-5164190334D7

P478

Q34313298-136FFC5A-032D-4851-A1F0-804AADFACE69

P577

Q34313298-1580F1C5-800A-4DB4-B3F8-ADCACEDB23D9

P698

Q34313298-A0B03E6C-5EBD-4CC2-8F59-C16479193F20

P932

Q34313298-1F18D6A7-1571-4A72-8EFF-91367A2E4656

P356

1078-0432.CCR-05-0596

P1433

Clinical Cancer Research

P1476

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

@en

P2093

Claudia Palena

http://www.w3.org/2001/XMLSchema#string

Ira Pastan

http://www.w3.org/2001/XMLSchema#string

Jeffrey Schlom

http://www.w3.org/2001/XMLSchema#string

Junko Yokokawa

http://www.w3.org/2001/XMLSchema#string

Kwong Y Tsang

http://www.w3.org/2001/XMLSchema#string

Mitchell Ho

http://www.w3.org/2001/XMLSchema#string

Philip Arlen

http://www.w3.org/2001/XMLSchema#string

Raffit Hassan

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

Molecular cloning and functional characterization of human lymphotactin

Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

Lymphotactin: a cytokine that represents a new class of chemokine

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

Mesothelin: a new target for immunotherapy

Molecular cloning and expression of megakaryocyte potentiating factor cDNA

Lymphotactin gene expression in mast cells following Fc(epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin A

P304

6342-6351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-05-0596

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16144939

http://www.w3.org/2001/XMLSchema#string

P932

1351144

http://www.w3.org/2001/XMLSchema#string